C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
11/2001
11/15/2001	WO2001085680A2 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
11/15/2001	WO2001008672A3 Glucamine compounds for treating hepatitis virus infections
11/15/2001	WO2000071507A3 INHIBITORS OF FACTOR Xa
11/14/2001	EP1153016A1 Phenylsulfonyl ureas, methods for producing them and their use as herbicides and plant growth regulators
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316484 Pentafluorobenzenesulfonamides and analogs
11/13/2001	US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors
11/08/2001	WO2001083431A1 Mmp-12 inhibitors
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001049657A8 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors
11/08/2001	WO2001023352A3 Preparation of sulfonyl imine compounds
11/08/2001	US20010039247 Pesticidal compositions
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/07/2001	EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	USRE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
11/06/2001	US6313345 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/06/2001	US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001	US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081297A1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010037033 Stereoselective, efficient catalyst for synthesis of enantiomerically pure compounds; comprising compex of transition metal and aminophosphine ligand
11/01/2001	US20010036944 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
11/01/2001	US20010036940 Chemical intermediates
11/01/2001	US20010036479 Having preferred particle size distribution characteristics; antidiabetic agent
11/01/2001	CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	CA2375068A1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
10/2001
10/31/2001	EP1149072A1 Sulfonamide hydroxamates
10/31/2001	EP0901466B1 Biphenylsulfonamide matrix metalloproteinase inhibitors
10/31/2001	CN1319589A Process for preparing sulfimine compound
10/30/2001	US6310206 Method for the production of N-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides and new intermediate products
10/30/2001	US6310078 Substituted amino acids as erythropoietin mimetics
10/30/2001	US6310060 For use as antiproliferative agent for use against cancer, psoriasis, restenosis, autoimmune disease, or atherosclerosis
10/30/2001	CA1341313C Photostable filtering cosmetic emulsion based on beneze-1,4-di(3-methylidene-10-campho-sulfonic) acid and at least one liposoluble uv-a filter
10/25/2001	WO2001079162A2 INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
10/25/2001	WO2001079161A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDE DERIVATIVES
10/25/2001	WO2001079160A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
10/25/2001	WO2001079159A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDES
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001079153A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
10/25/2001	WO2001079152A1 Sphingolipids
10/25/2001	WO2001078611A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	WO2001019798A3 Inhibitors of factor xa
10/25/2001	US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001	US20010034371 Antidiabetic agents
10/25/2001	US20010034369 Prevention, therapy thrombosis, restenosis
10/25/2001	CA2406903A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	CA2406247A1 Inhibitors of the ice/ced-3 family of cysteine proteases
10/25/2001	CA2404263A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amide derivatives
10/25/2001	CA2403563A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amides
10/24/2001	EP1148048A2 Polyaromatic antiviral compositions
10/24/2001	EP1147079A2 Beta-phenylalanine derivatives as integrin antagonists
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146865A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
10/24/2001	EP0823902B1 Process for preparing 1,1'- 1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane
10/24/2001	CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319086A Anthranilic acid derivatives
10/24/2001	CN1319014A Use of benzenesulfonyl (thio) ureas for treatment and prophylaxis of dysfunctions of autonomous nervous system and use of benzenesulfonyl(thio) ureas in combination with beta-receptor blockers
10/24/2001	CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307064 Process to prepare taxol
10/23/2001	US6306959 Rapid purification by polymer supported quench
10/23/2001	US6306840 Cell adhesion inhibitors
10/23/2001	US6306798 Compounds for controlling insects and representatives of the order acarina
10/23/2001	US6306179 Method for the synthesis of 2-hydroxyalkyl-para-phenylenediamines, new 2-hydroxyalkyl-para-phenylenediamines, their use for oxidation dyeing, dyeing compositions and methods of dyeing
10/18/2001	WO2001077077A1 Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031788 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/17/2001	EP1146037A1 Process for the preparation of optically active amino alcohols
10/17/2001	EP1145078A1 Photographic couplers having improved image dye light stability
10/17/2001	EP1144373A2 Serine protease inhibitors
10/17/2001	EP1144372A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
10/17/2001	EP1144371A1 Benzenesulphonamide derivatives and their use as mek inhibitors
10/17/2001	EP1144370A2 Thyroid receptor ligands
10/17/2001	EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
10/17/2001	EP1144066A1 Dehydration process
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	CN1073098C Benzothiazolone derivatives
10/17/2001	CN1073081C Naphthol derivatives and process for producing same
10/16/2001	US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001	US6303636 Arylsulfonylamino hydroxamic acid derivatives
10/16/2001	US6303630 Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus
10/11/2001	WO2001074761A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/11/2001	CA2404628A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/10/2001	EP1142867A2 Cell adhesion inhibitors
10/10/2001	EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001	EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001	EP1140846A1 Aspartic protease inhibitors
10/10/2001	EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001	EP1140823A1 Glucagon antagonists/inverse agonists

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 177